GE11 peptide modified CSO-SPION micelles for MRI diagnosis of targeted hepatic carcinoma

References

• Sia D, Villanueva A, Friedman SL, et al. Liver cancer cell of origin, molecular class, and effects on patient prognosis. Gastroenterology. 2017;152(4):745–761.
   PubMed Web of Science ®Google Scholar
• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.
   PubMed Web of Science ®Google Scholar
• Zheng XC, Ren W, Zhang S, et al. The theranostic efficiency of tumor-specific, pH-responsive, peptide-modified, liposome-containing paclitaxel and superparamagnetic iron oxide nanoparticles. Int J Nanomed. 2018;13:1495–1504. PubMed PMID: 29559778; PubMed Central PMCID: PMC5856286.
   PubMed Web of Science ®Google Scholar
• Wen L, Yang S, Zhong J, et al. Thermoacoustic imaging and therapy guidance based on ultra-short pulsed microwave pumped thermoelastic effect induced with superparamagnetic iron oxide nanoparticles. Theranostics. 2017;7(7):1976–1989. PubMed PMID: 28638483; PubMed Central PMCID: PMC5479284.
   PubMed Web of Science ®Google Scholar
• Shen X, Li T, Chen Z, et al. Luminescent/magnetic PLGA-based hybrid nanocomposites: a smart nanocarrier system for targeted codelivery and dual-modality imaging in cancer theranostics. Int J Nanomed. 2017;12:4299–4322. PubMed PMID: 28652734; PubMed Central PMCID: PMC5473604.
   PubMed Web of Science ®Google Scholar
• Singh N, Jenkins GJ, Asadi R, et al. Potential toxicity of superparamagnetic iron oxide nanoparticles (SPION). Nano Rev. 2010;1(1):5358. PMID: 22110864; PubMed Central PMCID: PMC3215220.
   PubMedGoogle Scholar
• Huang G, Li H, Chen J, et al. Tunable T1 and T2 contrast abilities of manganese-engineered iron oxide nanoparticles through size control. Nanoscale. 2014;6(17):10404–10412.
   PubMed Web of Science ®Google Scholar
• Gao Z, Ma T, Zhao E, et al. Small is smarter: nano MRI contrast agents – advantages and recent achievements. Small. 2016;12(5):556–576.
   PubMed Web of Science ®Google Scholar
• Zhou Z, Wu C, Liu H, et al. Surface and interfacial engineering of iron oxide nanoplates for highly efficient magnetic resonance angiography. ACS Nano. 2015;9(3):3012–3022.
   PubMed Web of Science ®Google Scholar
• Tang S, Du Q, Liu T, et al. In vivo magnetic resonance imaging and microwave thermotherapy of cancer using novel chitosan microcapsules. Nanoscale Res Lett. 2016;11(1):334. PubMed PMID: 27422776; PubMed Central PMCID: PMC4947076.
   PubMedGoogle Scholar
• Maeda H, Tsukigawa K, Fang J. A retrospective 30 years after discovery of the enhanced permeability and retention effect of solid tumors: next-generation chemotherapeutics and photodynamic therapy-problems, solutions, and prospects. Microcirculation. 2016;23(3):173–182.
   PubMed Web of Science ®Google Scholar
• Xiao Y, Lin ZT, Chen Y, et al. High molecular weight chitosan derivative polymeric micelles encapsulating superparamagnetic iron oxide for tumor-targeted magnetic resonance imaging. Int J Nanomed. 2015;10:1155–1172. PubMed PMID: 25709439; PubMed Central PMCID: PMC4330038.
   PubMed Web of Science ®Google Scholar
• Gholami L, Tafaghodi M, Abbasi B, et al. Preparation of superparamagnetic iron oxide/doxorubicin loaded chitosan nanoparticles as a promising glioblastoma theranostic tool. J Cell Physiol. 2019;234(2):1547–1559.
   PubMed Web of Science ®Google Scholar
• Chi YH, Hsiao JK, Lin MH, et al. Lung cancer-targeting peptides with multi-subtype indication for combinational drug delivery and molecular imaging. Theranostics. 2017;7(6):1612–1632. PubMed PMID: 28529640; PubMed Central PMCID: PMCPmc5436516. eng.
   PubMed Web of Science ®Google Scholar
• D’Aguanno S, Del Bufalo D. Inhibition of anti-apoptotic Bcl-2 proteins in preclinical and clinical studies: current overview in cancer. Cells. 2020;9(5):1287. PubMed PMID: 32455818; PubMed Central PMCID: PMC7291206.
   PubMed Web of Science ®Google Scholar
• Oerlemans C, Bult W, Bos M, et al. Polymeric micelles in anticancer therapy: targeting, imaging and triggered release. Pharm Res. 2010;27(12):2569–2589. PubMed PMID: 20725771; PubMed Central PMCID: PMC2982955.
   PubMed Web of Science ®Google Scholar
• Yang L, Mao H, Cao Z, et al. Molecular imaging of pancreatic cancer in an animal model using targeted multifunctional nanoparticles. Gastroenterology. 2009;136(5):1514–1525.e2. PubMed PMID: 19208341; PubMed Central PMCID: PMCPmc3651919. eng.
   PubMed Web of Science ®Google Scholar
• Scaltriti M, Baselga J. The epidermal growth factor receptor pathway: a model for targeted therapy. Clin Cancer Res. 2006;12(18):5268–5272.
   PubMed Web of Science ®Google Scholar
• Garousi J, Andersson KG, Mitran B, et al. PET imaging of epidermal growth factor receptor expression in tumours using 89Zr-labelled ZEGFR:2377 affibody molecules. Int J Oncol. 2016;48(4):1325–1332. PubMed PMID: 26847636; PubMed Central PMCID: PMC4777594.
   PubMed Web of Science ®Google Scholar
• Komposch K, Sibilia M. EGFR signaling in liver diseases. IJMS. 2015;17(1):30. PubMed PMID: 26729094; PubMed Central PMCID: PMC4730276.
   Google Scholar
• Zhou C, Xia Y, Wei Y, et al. GE11 peptide-installed chimaeric polymersomes tailor-made for high-efficiency EGFR-targeted protein therapy of orthotopic hepatocellular carcinoma. Acta Biomater. 2020;113:512–521.
   PubMed Web of Science ®Google Scholar
• Chang L, Wang G, Jia T, et al. Armored long non-coding RNA MEG3 targeting EGFR based on recombinant MS2 bacteriophage virus-like particles against hepatocellular carcinoma. Oncotarget. 2016;7(17):23988–24004. PubMed PMID: 26992211; PubMed Central PMCID: PMC5029679.
   PubMedGoogle Scholar
• Mickler FM, Mockl L, Ruthardt N, et al. Tuning nanoparticle uptake: live-cell imaging reveals two distinct endocytosis mechanisms mediated by natural and artificial EGFR targeting ligand. Nano Lett. 2012;12(7):3417–3423.
   PubMed Web of Science ®Google Scholar
• Ling D, Hyeon T. Chemical design of biocompatible iron oxide nanoparticles for medical applications. Small. 2013;9(9–10):1450–1466.
   PubMed Web of Science ®Google Scholar
• Saesoo S, Sathornsumetee S, Anekwiang P, et al. Characterization of liposome-containing SPIONs conjugated with anti-CD20 developed as a novel theranostic agent for central nervous system lymphoma. Colloids Surf B Biointerfaces. 2018;161:497–507.
   PubMed Web of Science ®Google Scholar
• Tom G, Philip S, Isaac R, et al. Preparation of an efficient and safe polymeric-magnetic nanoparticle delivery system for sorafenib in hepatocellular carcinoma. Life Sci. 2018;206:10–21.
   PubMed Web of Science ®Google Scholar
• Baxi SM, Tan W, Murphy ST, et al. Targeting 3-phosphoinoside-dependent kinase-1 to inhibit insulin-like growth factor-I induced AKT and p70 S6 kinase activation in breast cancer cells. PloS One. 2012;7(10):e48402. PubMed PMID: 23119004; PubMed Central PMCID: PMC3485233.
   PubMed Web of Science ®Google Scholar
• Huan H, Wen X, Chen X, et al. C/EBPα short-activating RNA suppresses metastasis of hepatocellular carcinoma through inhibiting EGFR/β-Catenin signaling mediated EMT. PloS One. 2016;11(4):e0153117. PubMed PMID: 27050434; PubMed Central PMCID: PMCPmc4822802. eng.
   PubMed Web of Science ®Google Scholar
• Guo Y, Wu Z, Shen S, et al. Nanomedicines reveal how PBOV1 promotes hepatocellular carcinoma for effective gene therapy. Nat Commun. 2018;9(1):3430.
   PubMedGoogle Scholar
• Liu X, Tian S, Liu M, et al. Wogonin inhibits the proliferation and invasion, and induces the apoptosis of HepG2 and Bel7402 HCC cells through NF‑κB/Bcl-2, EGFR and EGFR downstream ERK/AKT signaling . Int J Mol Med. 2016;38(4):1250–1256.
   PubMed Web of Science ®Google Scholar
• Fan Y, Huang Y. The effective peroxidase-like activity of chitosan-functionalized CoFe2O4 nanoparticles for chemiluminescence sensing of hydrogen peroxide and glucose. Analyst. 2012;137(5):1225–1231.
   PubMed Web of Science ®Google Scholar
• Fernandez-Lucas J, Harris R, Mata-Casar I, et al. Magnetic chitosan beads for covalent immobilization of nucleoside 2’-deoxyribosyltransferase: application in nucleoside analogues synthesis. J Ind Microbiol Biotechnol. 2013;40(9):955–966.
   PubMed Web of Science ®Google Scholar
• Jiang J, Li J, Zhou B, et al. Fabrication of polymer micelles with zwitterionic shell and biodegradable core for reductively responsive release of doxorubicin. Polymers. 2019;11(6):1019. PubMed PMID: 31181866; PubMed Central PMCID: PMC6631697.
   PubMed Web of Science ®Google Scholar
• Situ JQ, Wang XJ, Zhu XL, et al. Multifunctional SPIO/DOX-loaded A54 homing peptide functionalized dextran-g-PLGA micelles for tumor therapy and MR imaging. Sci Rep. 2016;6:35910. PubMed PMID: 27775017; PubMed Central PMCID: PMC5075939.
   PubMed Web of Science ®Google Scholar
• Wang Z, Qiao R, Tang N, et al. Active targeting theranostic iron oxide nanoparticles for MRI and magnetic resonance-guided focused ultrasound ablation of lung cancer. Biomaterials. 2017;127:25–35. PubMed PMID: 28279919; PubMed Central PMCID: PMC5400286.
   PubMed Web of Science ®Google Scholar
• Jain TK, Morales MA, Sahoo SK, et al. Iron oxide nanoparticles for sustained delivery of anticancer agents. Mol Pharm. 2005;2(3):194–205.
   PubMed Web of Science ®Google Scholar
• Liu Y, Huang W, Xiong C, et al. Biodistribution and sensitive tracking of immune cells with plasmonic gold nanostars. Int J Nanomed. 2019;14:3403–3411. PubMed PMID: 31190799; PubMed Central PMCID: PMC6514259.
   PubMed Web of Science ®Google Scholar
• Chen X, Zhou H, Li X, et al. Plectin-1 targeted dual-modality nanoparticles for pancreatic cancer imaging. EBioMedicine. 2018;30:129–137. PubMed PMID: 29574092; PubMed Central PMCID: PMC5952251.
   PubMed Web of Science ®Google Scholar